Professor Clare Scott is a clinician scientist and head of the ovarian cancer laboratory at WEHI. Her expertise in novel pre-clinical mouse models of epithelial ovarian cancer complements her involvement in ovarian cancer genetics and key contributions to clinical trials of the DNA repair inhibitors, PARP inhibitors. The focus of Scott’s laboratory is discovery, leading to the design of novel treatments targeted to a range of specific molecular drivers and susceptibilities of epithelial ovarian cancers and other rare cancer subtypes. She has built strong links with the community and is improving clinical and research opportunities for Australians with rare cancers.